GRI
Price
$1.17
Change
-$0.09 (-7.14%)
Updated
Aug 11, 03:07 PM (EDT)
Capitalization
3.15M
SNSE
Price
$7.65
Change
+$0.44 (+6.10%)
Updated
Aug 8 closing price
Capitalization
9.64M
Interact to see
Advertisement

GRI vs SNSE

Header iconGRI vs SNSE Comparison
Open Charts GRI vs SNSEBanner chart's image
GRI Bio
Price$1.17
Change-$0.09 (-7.14%)
Volume$500
Capitalization3.15M
Sensei Biotherapeutics
Price$7.65
Change+$0.44 (+6.10%)
Volume$81.47K
Capitalization9.64M
GRI vs SNSE Comparison Chart in %
Loading...
GRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GRI vs. SNSE commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRI is a Hold and SNSE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (GRI: $1.26 vs. SNSE: $7.65)
Brand notoriety: GRI and SNSE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GRI: 22% vs. SNSE: 415%
Market capitalization -- GRI: $3.15M vs. SNSE: $9.64M
GRI [@Biotechnology] is valued at $3.15M. SNSE’s [@Biotechnology] market capitalization is $9.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRI’s FA Score shows that 2 FA rating(s) are green whileSNSE’s FA Score has 1 green FA rating(s).

  • GRI’s FA Score: 2 green, 3 red.
  • SNSE’s FA Score: 1 green, 4 red.
According to our system of comparison, GRI is a better buy in the long-term than SNSE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRI’s TA Score shows that 4 TA indicator(s) are bullish while SNSE’s TA Score has 4 bullish TA indicator(s).

  • GRI’s TA Score: 4 bullish, 6 bearish.
  • SNSE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both GRI and SNSE are a bad buy in the short-term.

Price Growth

GRI (@Biotechnology) experienced а -4.55% price change this week, while SNSE (@Biotechnology) price change was -25.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.41%. For the same industry, the average monthly price growth was +31.91%, and the average quarterly price growth was +19.35%.

Industries' Descriptions

@Biotechnology (+22.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNSE($9.64M) has a higher market cap than GRI($3.15M). SNSE YTD gains are higher at: -21.955 vs. GRI (-91.053). GRI has less debt than SNSE: GRI (108K) vs SNSE (3.21M).
GRISNSEGRI / SNSE
Capitalization3.15M9.64M33%
EBITDA-9.39MN/A-
Gain YTD-91.053-21.955415%
P/E Ratio0.03N/A-
Revenue0N/A-
Total Cash3.28MN/A-
Total Debt108K3.21M3%
FUNDAMENTALS RATINGS
GRI: Fundamental Ratings
GRI
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GRISNSE
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
83%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
88%
Bullish Trend 11 days ago
76%
Declines
ODDS (%)
Bearish Trend 25 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DGX176.962.69
+1.54%
Quest Diagnostics
SFNC18.940.23
+1.26%
Simmons First National Corp
LTRX2.990.02
+0.67%
Lantronix
OXM38.890.15
+0.39%
Oxford Industries
APRE1.65N/A
N/A
Aprea Therapeutics

GRI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRI has been loosely correlated with AMLX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if GRI jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRI
1D Price
Change %
GRI100%
+0.80%
AMLX - GRI
57%
Loosely correlated
-2.55%
ATRA - GRI
40%
Loosely correlated
-0.05%
SNSE - GRI
39%
Loosely correlated
+6.10%
INAB - GRI
37%
Loosely correlated
+7.44%
SLRX - GRI
34%
Loosely correlated
-10.07%
More

SNSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with HURA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then HURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
+6.10%
HURA - SNSE
48%
Loosely correlated
-5.35%
VSTM - SNSE
46%
Loosely correlated
+19.93%
MOLN - SNSE
42%
Loosely correlated
N/A
GRI - SNSE
39%
Loosely correlated
+0.80%
INAB - SNSE
37%
Loosely correlated
+7.44%
More